Pyrrolidine compounds and methods for selective inhibition...

Details Pyrrolidine compounds and methods for selective inhibition... Pyrrolidine compounds and methods for selective inhibition...

2011-03-15

2011-03-15

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S064000

Reexamination Certificate

active

07906658

ABSTRACT:
The present invention is directed to a method of treatment of a malcondition that can be regulated or normalized via inhibition of DPP-IV. The method involves administration of an effective amount of a pyrrolidine compound of the invention, such as would be present in a pharmaceutical composition of the invention, to mammals, especially humans, to affect a malcondition that can be regulated or normalized via inhibition of DPP-IV.

REFERENCES:
patent: 3674836 (1972-07-01), Creger
patent: 3983140 (1976-09-01), Endo et al.
patent: 4027009 (1977-05-01), Grier et al.
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4448784 (1984-05-01), Glamkowski et al.
patent: 4450171 (1984-05-01), Hoffman et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4681893 (1987-07-01), Roth
patent: 4759923 (1988-07-01), Buntin et al.
patent: 4871721 (1989-10-01), Biller
patent: 4924024 (1990-05-01), Biller
patent: 4935493 (1990-06-01), Bachovchin et al.
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5011930 (1991-04-01), Fujikawa et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5273995 (1993-12-01), Roth
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5385929 (1995-01-01), Bjorge et al.
patent: 5447954 (1995-09-01), Gribble et al.
patent: 5462928 (1995-10-01), Bachovchin et al.
patent: 5488064 (1996-01-01), Sher
patent: 5491134 (1996-02-01), Sher et al.
patent: 5541204 (1996-07-01), Sher et al.
patent: 5574017 (1996-11-01), Gutheil
patent: 5594016 (1997-01-01), Ueno et al.
patent: 5595872 (1997-01-01), Wetterau, II et al.
patent: 5614492 (1997-03-01), Habener
patent: 5631224 (1997-05-01), Efendic et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 5712279 (1998-01-01), Biller et al.
patent: 5712396 (1998-01-01), Magnin et al.
patent: 5739135 (1998-04-01), Biller et al.
patent: 5760246 (1998-06-01), Biller et al.
patent: 5770615 (1998-06-01), Cheng et al.
patent: 5776983 (1998-07-01), Washburn et al.
patent: 5827875 (1998-10-01), Dickson, Jr. et al.
patent: 5885983 (1999-03-01), Biller et al.
patent: 5952301 (1999-09-01), Drucker
patent: 5952322 (1999-09-01), Hoover et al.
patent: 5962440 (1999-10-01), Sulsky
patent: 5965532 (1999-10-01), Bachovchin
patent: 5998463 (1999-12-01), Hulin et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 6040145 (2000-03-01), Huber et al.
patent: 6107317 (2000-08-01), Villhauer
patent: 6110949 (2000-08-01), Villhauer
patent: 6124305 (2000-09-01), Villhauer
patent: 6166063 (2000-12-01), Villhauer
patent: 6172081 (2001-01-01), Damon
patent: 6258597 (2001-07-01), Bachovchin et al.
patent: 6300314 (2001-10-01), Wallner et al.
patent: 6303661 (2001-10-01), Demuth et al.
patent: 6355614 (2002-03-01), Wallner
patent: 6380398 (2002-04-01), Kanstrup et al.
patent: 6395767 (2002-05-01), Robl et al.
patent: 6432969 (2002-08-01), Villhauer
patent: 6617340 (2003-09-01), Villhauer
patent: 6989402 (2006-01-01), Hangeland et al.
patent: 7317109 (2008-01-01), Campbell et al.
patent: 7576121 (2009-08-01), Campbell et al.
patent: 7674913 (2010-03-01), Campbell et al.
patent: 2003/0100563 (2003-05-01), Edmondson et al.
patent: 2003/0153509 (2003-08-01), Bachovchin et al.
patent: 2006/0258621 (2006-11-01), Campbell et al.
patent: 2006/0264400 (2006-11-01), Campbell et al.
patent: 2006/0264401 (2006-11-01), Campbell et al.
patent: 2006/0276410 (2006-12-01), Campbell et al.
patent: 2007/0185061 (2007-08-01), Campbell
patent: 2008/0182995 (2008-07-01), Campbell et al.
patent: 2010/0120661 (2010-05-01), Campbell et al.
patent: 2121369AA (1992-04-01), None
patent: 2334155AA (1999-12-01), None
patent: 2468192AA (2003-06-01), None
patent: 19616486 (1997-10-01), None
patent: 0818448 (1998-01-01), None
patent: 0896538 (1999-02-01), None
patent: 0978279 (2000-02-01), None
patent: 1041068 (2004-04-01), None
patent: 20060121170 (2006-11-01), None
patent: WO-8903223 (1989-04-01), None
patent: WO-9116339 (1991-10-01), None
patent: WO-9308259 (1993-04-01), None
patent: WO-9310127 (1993-05-01), None
patent: WO-9511689 (1995-05-01), None
patent: WO-9515309 (1995-06-01), None
patent: WO-9639384 (1996-12-01), None
patent: WO-9639385 (1996-12-01), None
patent: WO-9712613 (1997-04-01), None
patent: WO-9712615 (1997-04-01), None
patent: WO-9721993 (1997-06-01), None
patent: WO-9800439 (1998-01-01), None
patent: WO-9819998 (1998-05-01), None
patent: WO-9850046 (1998-11-01), None
patent: WO-9900353 (1999-01-01), None
patent: WO-9903850 (1999-01-01), None
patent: WO-9926659 (1999-06-01), None
patent: WO-9938501 (1999-08-01), None
patent: WO-9943663 (1999-09-01), None
patent: WO-0034241 (2000-06-01), None
patent: WO-0038722 (2000-07-01), None
patent: WO-0047206 (2000-08-01), None
patent: WO-03045228 (2003-06-01), None
patent: WO-03045977 (2003-06-01), None
patent: WO-03045977 (2003-06-01), None
patent: WO-03082817 (2003-10-01), None
patent: WO-2004004661 (2004-01-01), None
patent: WO-2004044661 (2004-05-01), None
patent: WO-2005/047297 (2005-05-01), None
patent: WO-2005075426 (2005-08-01), None
patent: WO-2006040625 (2006-04-01), None
“U.S. Appl. No. 11/381,090, Final Office Action Mailed Nov. 4, 2009”, 10 pgs.
“U.S. Appl. No. 10/514,575, Final Office Action mailed Nov. 10, 2009”, 21 Pgs.
“U.S. Appl. No. 10/514,575, Notice of Allowance mailed Jan. 13, 2010”, 9 pgs.
“U.S. Appl. No. 10/514,575, Response filed Dec. 17, 2009 to Final Office Action mailed Nov. 10, 2009”, 6 pgs.
“U.S. Appl. No. 11/381,090 , Notice of Allowance mailed Jan. 12, 2010”, 8 Pgs.
“U.S. Appl. No. 11/381,090 Final Office Action mailed Nov. 4, 2009”, 10 pgs.
“U.S. Appl. No. 11/381,090, Response filed Dec. 16, 2009 to Final Office Action mailed Nov. 4, 2009”, 11 pgs.
“U.S. Appl. No. 11/930,337, Preliminary Amendment mailed Feb. 11, 2010”, 5 pgs.
“Eurasian Application No. 200600935, Notice of Allowance mailed Dec. 28, 2009”, 1 pg.
“Taiwanese Application Serial No. 093134776, Office Action Mailed Feb. 12, 2010”, 5 pgs.
“U.S. Appl. No. 10/514,575, Non-Final Office Action mailed Dec. 29, 2008”, 17 pgs.
“U.S. Appl. No. 10/514,575, Response filed Mar. 23, 2009 to Non Final Office Action mailed Dec. 29, 2008”, 31 pgs.
“U.S. Appl. No. 11/381,082, Final Office Action mailed Sep. 19, 2008”, 14 pgs.
“U.S. Appl. No. 11/381,082, Non-Final Office Action mailed Mar. 17, 2008”, 15 pgs.
“U.S. Appl. No. 11/381,082, Notice of Allowance mailed Apr. 17, 2009”, 7 pgs.
“U.S. Appl. No. 11/381,082, Notice of Allowance mailed Dec. 31, 2008”, 7 pgs.
“U.S. Appl. No. 11/381,082, Response filed Jun. 17, 2008 to Non Final Office Action mailed Mar. 17, 2008”, 21 pgs.
“U.S. Appl. No. 11/381,082, Response filed Nov. 19, 2008 to Final Office Action mailed Sep. 19, 2008”, 26 pgs.
“U.S. Appl. No. 11/381,090, Final Office Action mailed Dec. 22, 2008”, 11 pgs.
“U.S. Appl. No. 11/381,090, Response filed Mar. 20, 2009 to Final Office Action mailed Dec. 22, 2008”, 13 pgs.
“Canadian Application Serial No. 2,545,311, Office Action mailed Mar. 17, 2009”, 6 pgs.
“Canadian Application Serial No. 2,602,772, Office Action Mailed Mar. 2, 2009”, 32 pgs.
“Chinese Application Serial No. 200480037257.9, Office Action Mailed Dec. 5, 2008”, 10 pgs.
“Korean Application Serial No. 10-2006-7011419, Office action Mailed Feb. 23, 2009”, 2 pgs.
“Point Therapeutics”, http://www.pther.com, http://web.archive.org/web/20070827113729/http://www.pther.com/, 2008.
Augustyns, K., et al., “The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors”,Curr Med Chem., 6(4), (Apr. 1999), 311-27.
Balkan, B., et al., “Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves

Affiliated with

Also associated with

Rating

Pyrrolidine compounds and methods for selective inhibition... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolidine compounds and methods for selective inhibition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine compounds and methods for selective inhibition... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2643169